Merck & Co has offered a hefty $9.5 billion to take control of US biotech Cubist Pharmaceuticals, in another signal that big pharma's interest in antibiotics research is returning. Merck is offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback